The AHSN Network was commissioned by NHS England to support Mental Health Trusts with the adoption of the Serenity Integrated Mentoring (SIM) model between April 2018 and March 2020. NHS England has now written to Trusts to ask that SIM and SIM-like models stop. The service users for this model have complex mental health needs and are among the most vulnerable in society, so the Network was deeply concerned to hear of the issues outlined in NHS England’s letter; any withholding of care is clearly unacceptable.

In 2021, the AHSN Network commissioned an Independent Review into its role in supporting the adoption of SIM, following concerns raised about the model on social media. The Independent Review focused on the context, decisions and processes that led to the selection of SIM as a national programme, commissioned by NHS England. The Independent Review did not consider the merits or demerits of the model as this was the subject of a review initiated by NHS England in 2021.

During the two years that SIM was an AHSN national programme, AHSNs recognised a need for a more rigorous evaluation of SIM, and the Network supported applications to the National Institute for Health and Care Research (NIHR) for more extensive research studies, which included qualitative assessments of service user experience. Those research bids were however unsuccessful.

The Independent Review into the AHSN role in SIM was commissioned by the Network as an internal learning exercise and AHSNs have used the recommendations in the review to improve and enhance our processes relating to the identification and spread of innovation.

When SIM was adopted among the first set of AHSN National Programmes, it marked the start of AHSNs working together as a national Network. Five years on, the AHSN Network systems and processes for developing and supporting national programmes have undergone significant development; as has our experience of supporting adoption at scale.

The majority of the recommendations within this independent review have already been implemented. Notably, we now ensure evaluations are built into programme plans from inception; a phased approach to national spread of promising innovations has been adopted; and patient and public involvement is central to innovations put forward for national spread.

However, the AHSN Network is committed to learning from feedback from service users, clinicians and other partners regarding the innovations and service models it supports, and will continually review and update its processes.

Read the full AHSN Network response to the Independent Review. 

Read the full ‘Independent Review’ into the AHSN Network role in SIM

  • Polypharmacy Action Learning Set celebrates 1000th delegate

    Lesley Bull, a South London GP and our 1000th delegate chats to Lois-Hooper Ainsworth, Programme Coordinator on the National Polypharmacy Programme, about why she registered for the Health Innovation Network Polypharmacy Action Learning Set, what she got out of it and why other GPs should attend. Lesley Bull So, Lesley, could you tell [...]

  • Meet the innovator: Jo Barosa, Qbtech

    Jo Barosa is Account Director at Qbtech UK. Qbtech is a market leading provider of innovative objective tests for assessing and treating ADHD, changing the landscape of ADHD care. Driven by its mission to improve the lives of people with ADHD, Qbtech supports by providing digital and clinical solutions to improve clinical decision making, service [...]

  • Prevention may be the cure, but innovation the best course of treatment

    Dr Cheryl Crocker, interim Chief Operating Officer at the Health Innovation Network, explains the vital role innovation plays to not only reduce waiting lists and improve access to care, but to decrease system pressure by improving people’s health and keeping them well for longer.  The new Government has rightly declared its focus on moving the [...]